Australia, April 29 -- Actor Pharmaceuticals Pty. Ltd., owns the trademark (2588103) for 'TRAVAMINE' till Sept. 18, 2035.
Status: registered:
Registered/protected
Class: 5 [nausea treatment preparations; antiemetics; antihistamines; allergy relief medication; motion sickness medicines; anti-motion sickness agents]
Type of Mark: Word
Date of Acceptance: Oct. 1, 2025
Registration Advertised: April 28
For further details contact MBIP.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2588103.
Disclaimer: Curated by HT Syndication.